Global Artificial Skin Market
Global Artificial Skin Market

Artificial Skin Comprehensive Study by Type (Epidermal Skin Material, Dermal Skin Material), Need of Patient (Spray-on Skin, Temporary Skin Graft, Permanent Skin Graft, Artificial Electric Skin (e-Skin), Gelatin-Contained Artificial Skin, Composite Biocompatible Epidermal Graft), Distribution Channel (Retail Pharmacies, Hospitals, Others), Material Type (Composite Skin Material, Permanent Skin Material, Temporary Skin Material) Players and Region - Global Market Outlook to 2024

Artificial Skin Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 212 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Artificial Skin Market Overview:
Artificial skin, a collagen scaffold, is a synthetic skin that induces regeneration of the skin in mammals includes humans. It is used to replace the human skin to save patients from burns injuries and other skin infections. Moreover, increasing adaptation of the skin regeneration treatments in plastic surgery and rise in awareness of artificial skin products is boosting the growth of the very market globally.

Market Drivers
  • Increasing Adaptation of the Skin Regeneration Treatments in Plastic Surgery
  • Growing Life-Threatening Skin Injuries, Traumas and Burns Requires Immediate Surgical Procedure to Restore Skin

Market Trend
  • Continuous R&D to Develop New Technology in Artificial Skin Regeneration including Autologous Spray-on Skin by Key Market Players

Restraints
  • High Cost of the Treatment and Artificial Skin Products and Complications such as Acceptance by the Body

Opportunities
  • Rising Awareness of Artificial Skin Products in Developing Nations

Challenges
  • Lack of Awareness of Products and Services
  • Inadequate Medical Infrastructure and Low Access to Medical Facilities in Emerging Nations


Competitive Landscape:

Some of the key players profiled in the report are Integra Life Sciences Corporation (United States), Johnson & Johnson Services Inc. (United States), Mylan N.V. (United Kingdom), Mallinckrodt plc (United Kingdom), Smith & Nephew plc (United Kingdom), Shiseido Company, Limited (Japan), Greiner Group AG (Austria), Stratatech Corporation (United Kingdom) and Doctors Health Press (United States). Analyst at AdvanceMarketAnalytics see United Kingdom Players to retain maximum share of Global Artificial Skin market by 2024. Considering Market by Need of Patient, the sub-segment i.e. Spray-on Skin will boost the Artificial Skin market. Considering Market by Distribution Channel, the sub-segment i.e. Retail Pharmacies will boost the Artificial Skin market. Considering Market by Material Type, the sub-segment i.e. Composite Skin Material will boost the Artificial Skin market.

Market Highlights:

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Artificial Skin market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Artificial Skin market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Artificial Skin Regeneration Companies, Medical Companies, Pharmaceutical Companies, Biotechnology Companies, Technology Providers, End users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Epidermal Skin Material
  • Dermal Skin Material
By Need of Patient
  • Spray-on Skin
  • Temporary Skin Graft
  • Permanent Skin Graft
  • Artificial Electric Skin (e-Skin)
  • Gelatin-Contained Artificial Skin
  • Composite Biocompatible Epidermal Graft

By Distribution Channel
  • Retail Pharmacies
  • Hospitals
  • Others

By Material Type
  • Composite Skin Material
  • Permanent Skin Material
  • Temporary Skin Material

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adaptation of the Skin Regeneration Treatments in Plastic Surgery
      • 3.2.2. Growing Life-Threatening Skin Injuries, Traumas and Burns Requires Immediate Surgical Procedure to Restore Skin
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness of Products and Services
      • 3.3.2. Inadequate Medical Infrastructure and Low Access to Medical Facilities in Emerging Nations
    • 3.4. Market Trends
      • 3.4.1. Continuous R&D to Develop New Technology in Artificial Skin Regeneration including Autologous Spray-on Skin by Key Market Players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Skin, by Type, Need of Patient, Distribution Channel, Material Type and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Artificial Skin (Value)
      • 5.2.1. Global Artificial Skin by: Type (Value)
        • 5.2.1.1. Epidermal Skin Material
        • 5.2.1.2. Dermal Skin Material
      • 5.2.2. Global Artificial Skin by: Need of Patient (Value)
        • 5.2.2.1. Spray-on Skin
        • 5.2.2.2. Temporary Skin Graft
        • 5.2.2.3. Permanent Skin Graft
        • 5.2.2.4. Artificial Electric Skin (e-Skin)
        • 5.2.2.5. Gelatin-Contained Artificial Skin
        • 5.2.2.6. Composite Biocompatible Epidermal Graft
      • 5.2.3. Global Artificial Skin by: Distribution Channel (Value)
        • 5.2.3.1. Retail Pharmacies
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Others
      • 5.2.4. Global Artificial Skin by: Material Type (Value)
        • 5.2.4.1. Composite Skin Material
        • 5.2.4.2. Permanent Skin Material
        • 5.2.4.3. Temporary Skin Material
      • 5.2.5. Global Artificial Skin Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Artificial Skin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Integra Life Sciences Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson Services Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Mylan N.V. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mallinckrodt plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Smith & Nephew plc (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Shiseido Company, Limited (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Greiner Group AG (Austria)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Stratatech Corporation (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Doctors Health Press (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Artificial Skin Sale, by Type, Need of Patient, Distribution Channel, Material Type and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Artificial Skin (Value)
      • 7.2.1. Global Artificial Skin by: Type (Value)
        • 7.2.1.1. Epidermal Skin Material
        • 7.2.1.2. Dermal Skin Material
      • 7.2.2. Global Artificial Skin by: Need of Patient (Value)
        • 7.2.2.1. Spray-on Skin
        • 7.2.2.2. Temporary Skin Graft
        • 7.2.2.3. Permanent Skin Graft
        • 7.2.2.4. Artificial Electric Skin (e-Skin)
        • 7.2.2.5. Gelatin-Contained Artificial Skin
        • 7.2.2.6. Composite Biocompatible Epidermal Graft
      • 7.2.3. Global Artificial Skin by: Distribution Channel (Value)
        • 7.2.3.1. Retail Pharmacies
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Others
      • 7.2.4. Global Artificial Skin by: Material Type (Value)
        • 7.2.4.1. Composite Skin Material
        • 7.2.4.2. Permanent Skin Material
        • 7.2.4.3. Temporary Skin Material
      • 7.2.5. Global Artificial Skin Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Skin: by Type(USD Million)
  • Table 2. Artificial Skin Epidermal Skin Material , by Region USD Million (2013-2018)
  • Table 3. Artificial Skin Dermal Skin Material , by Region USD Million (2013-2018)
  • Table 4. Artificial Skin: by Need of Patient(USD Million)
  • Table 5. Artificial Skin Spray-on Skin , by Region USD Million (2013-2018)
  • Table 6. Artificial Skin Temporary Skin Graft , by Region USD Million (2013-2018)
  • Table 7. Artificial Skin Permanent Skin Graft , by Region USD Million (2013-2018)
  • Table 8. Artificial Skin Artificial Electric Skin (e-Skin) , by Region USD Million (2013-2018)
  • Table 9. Artificial Skin Gelatin-Contained Artificial Skin , by Region USD Million (2013-2018)
  • Table 10. Artificial Skin Composite Biocompatible Epidermal Graft , by Region USD Million (2013-2018)
  • Table 11. Artificial Skin: by Distribution Channel(USD Million)
  • Table 12. Artificial Skin Retail Pharmacies , by Region USD Million (2013-2018)
  • Table 13. Artificial Skin Hospitals , by Region USD Million (2013-2018)
  • Table 14. Artificial Skin Others , by Region USD Million (2013-2018)
  • Table 15. Artificial Skin: by Material Type(USD Million)
  • Table 16. Artificial Skin Composite Skin Material , by Region USD Million (2013-2018)
  • Table 17. Artificial Skin Permanent Skin Material , by Region USD Million (2013-2018)
  • Table 18. Artificial Skin Temporary Skin Material , by Region USD Million (2013-2018)
  • Table 19. South America Artificial Skin, by Country USD Million (2013-2018)
  • Table 20. South America Artificial Skin, by Type USD Million (2013-2018)
  • Table 21. South America Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 22. South America Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 23. South America Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 24. Brazil Artificial Skin, by Type USD Million (2013-2018)
  • Table 25. Brazil Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 26. Brazil Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 27. Brazil Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 28. Argentina Artificial Skin, by Type USD Million (2013-2018)
  • Table 29. Argentina Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 30. Argentina Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 31. Argentina Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 32. Rest of South America Artificial Skin, by Type USD Million (2013-2018)
  • Table 33. Rest of South America Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 34. Rest of South America Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 35. Rest of South America Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 36. Asia Pacific Artificial Skin, by Country USD Million (2013-2018)
  • Table 37. Asia Pacific Artificial Skin, by Type USD Million (2013-2018)
  • Table 38. Asia Pacific Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 39. Asia Pacific Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 40. Asia Pacific Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 41. China Artificial Skin, by Type USD Million (2013-2018)
  • Table 42. China Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 43. China Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 44. China Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 45. Japan Artificial Skin, by Type USD Million (2013-2018)
  • Table 46. Japan Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 47. Japan Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 48. Japan Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 49. India Artificial Skin, by Type USD Million (2013-2018)
  • Table 50. India Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 51. India Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 52. India Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 53. South Korea Artificial Skin, by Type USD Million (2013-2018)
  • Table 54. South Korea Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 55. South Korea Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 56. South Korea Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 57. Taiwan Artificial Skin, by Type USD Million (2013-2018)
  • Table 58. Taiwan Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 59. Taiwan Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 60. Taiwan Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 61. Australia Artificial Skin, by Type USD Million (2013-2018)
  • Table 62. Australia Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 63. Australia Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 64. Australia Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 65. Rest of Asia-Pacific Artificial Skin, by Type USD Million (2013-2018)
  • Table 66. Rest of Asia-Pacific Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 67. Rest of Asia-Pacific Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 69. Europe Artificial Skin, by Country USD Million (2013-2018)
  • Table 70. Europe Artificial Skin, by Type USD Million (2013-2018)
  • Table 71. Europe Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 72. Europe Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 73. Europe Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 74. Germany Artificial Skin, by Type USD Million (2013-2018)
  • Table 75. Germany Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 76. Germany Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 77. Germany Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 78. France Artificial Skin, by Type USD Million (2013-2018)
  • Table 79. France Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 80. France Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 81. France Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 82. Italy Artificial Skin, by Type USD Million (2013-2018)
  • Table 83. Italy Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 84. Italy Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 85. Italy Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 86. United Kingdom Artificial Skin, by Type USD Million (2013-2018)
  • Table 87. United Kingdom Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 88. United Kingdom Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 89. United Kingdom Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 90. Netherlands Artificial Skin, by Type USD Million (2013-2018)
  • Table 91. Netherlands Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 92. Netherlands Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 93. Netherlands Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 94. Rest of Europe Artificial Skin, by Type USD Million (2013-2018)
  • Table 95. Rest of Europe Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 96. Rest of Europe Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 97. Rest of Europe Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 98. MEA Artificial Skin, by Country USD Million (2013-2018)
  • Table 99. MEA Artificial Skin, by Type USD Million (2013-2018)
  • Table 100. MEA Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 101. MEA Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 102. MEA Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 103. Middle East Artificial Skin, by Type USD Million (2013-2018)
  • Table 104. Middle East Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 105. Middle East Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 106. Middle East Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 107. Africa Artificial Skin, by Type USD Million (2013-2018)
  • Table 108. Africa Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 109. Africa Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 110. Africa Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 111. North America Artificial Skin, by Country USD Million (2013-2018)
  • Table 112. North America Artificial Skin, by Type USD Million (2013-2018)
  • Table 113. North America Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 114. North America Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 115. North America Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 116. United States Artificial Skin, by Type USD Million (2013-2018)
  • Table 117. United States Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 118. United States Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 119. United States Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 120. Canada Artificial Skin, by Type USD Million (2013-2018)
  • Table 121. Canada Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 122. Canada Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 123. Canada Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 124. Mexico Artificial Skin, by Type USD Million (2013-2018)
  • Table 125. Mexico Artificial Skin, by Need of Patient USD Million (2013-2018)
  • Table 126. Mexico Artificial Skin, by Distribution Channel USD Million (2013-2018)
  • Table 127. Mexico Artificial Skin, by Material Type USD Million (2013-2018)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Artificial Skin: by Type(USD Million)
  • Table 138. Artificial Skin Epidermal Skin Material , by Region USD Million (2019-2024)
  • Table 139. Artificial Skin Dermal Skin Material , by Region USD Million (2019-2024)
  • Table 140. Artificial Skin: by Need of Patient(USD Million)
  • Table 141. Artificial Skin Spray-on Skin , by Region USD Million (2019-2024)
  • Table 142. Artificial Skin Temporary Skin Graft , by Region USD Million (2019-2024)
  • Table 143. Artificial Skin Permanent Skin Graft , by Region USD Million (2019-2024)
  • Table 144. Artificial Skin Artificial Electric Skin (e-Skin) , by Region USD Million (2019-2024)
  • Table 145. Artificial Skin Gelatin-Contained Artificial Skin , by Region USD Million (2019-2024)
  • Table 146. Artificial Skin Composite Biocompatible Epidermal Graft , by Region USD Million (2019-2024)
  • Table 147. Artificial Skin: by Distribution Channel(USD Million)
  • Table 148. Artificial Skin Retail Pharmacies , by Region USD Million (2019-2024)
  • Table 149. Artificial Skin Hospitals , by Region USD Million (2019-2024)
  • Table 150. Artificial Skin Others , by Region USD Million (2019-2024)
  • Table 151. Artificial Skin: by Material Type(USD Million)
  • Table 152. Artificial Skin Composite Skin Material , by Region USD Million (2019-2024)
  • Table 153. Artificial Skin Permanent Skin Material , by Region USD Million (2019-2024)
  • Table 154. Artificial Skin Temporary Skin Material , by Region USD Million (2019-2024)
  • Table 155. South America Artificial Skin, by Country USD Million (2019-2024)
  • Table 156. South America Artificial Skin, by Type USD Million (2019-2024)
  • Table 157. South America Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 158. South America Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 159. South America Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 160. Brazil Artificial Skin, by Type USD Million (2019-2024)
  • Table 161. Brazil Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 162. Brazil Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 163. Brazil Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 164. Argentina Artificial Skin, by Type USD Million (2019-2024)
  • Table 165. Argentina Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 166. Argentina Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 167. Argentina Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 168. Rest of South America Artificial Skin, by Type USD Million (2019-2024)
  • Table 169. Rest of South America Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 170. Rest of South America Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 171. Rest of South America Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 172. Asia Pacific Artificial Skin, by Country USD Million (2019-2024)
  • Table 173. Asia Pacific Artificial Skin, by Type USD Million (2019-2024)
  • Table 174. Asia Pacific Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 175. Asia Pacific Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 176. Asia Pacific Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 177. China Artificial Skin, by Type USD Million (2019-2024)
  • Table 178. China Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 179. China Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 180. China Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 181. Japan Artificial Skin, by Type USD Million (2019-2024)
  • Table 182. Japan Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 183. Japan Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 184. Japan Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 185. India Artificial Skin, by Type USD Million (2019-2024)
  • Table 186. India Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 187. India Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 188. India Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 189. South Korea Artificial Skin, by Type USD Million (2019-2024)
  • Table 190. South Korea Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 191. South Korea Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 192. South Korea Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 193. Taiwan Artificial Skin, by Type USD Million (2019-2024)
  • Table 194. Taiwan Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 195. Taiwan Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 196. Taiwan Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 197. Australia Artificial Skin, by Type USD Million (2019-2024)
  • Table 198. Australia Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 199. Australia Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 200. Australia Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 201. Rest of Asia-Pacific Artificial Skin, by Type USD Million (2019-2024)
  • Table 202. Rest of Asia-Pacific Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 203. Rest of Asia-Pacific Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 204. Rest of Asia-Pacific Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 205. Europe Artificial Skin, by Country USD Million (2019-2024)
  • Table 206. Europe Artificial Skin, by Type USD Million (2019-2024)
  • Table 207. Europe Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 208. Europe Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 209. Europe Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 210. Germany Artificial Skin, by Type USD Million (2019-2024)
  • Table 211. Germany Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 212. Germany Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 213. Germany Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 214. France Artificial Skin, by Type USD Million (2019-2024)
  • Table 215. France Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 216. France Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 217. France Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 218. Italy Artificial Skin, by Type USD Million (2019-2024)
  • Table 219. Italy Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 220. Italy Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 221. Italy Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 222. United Kingdom Artificial Skin, by Type USD Million (2019-2024)
  • Table 223. United Kingdom Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 224. United Kingdom Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 225. United Kingdom Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 226. Netherlands Artificial Skin, by Type USD Million (2019-2024)
  • Table 227. Netherlands Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 228. Netherlands Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 229. Netherlands Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 230. Rest of Europe Artificial Skin, by Type USD Million (2019-2024)
  • Table 231. Rest of Europe Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 232. Rest of Europe Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 233. Rest of Europe Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 234. MEA Artificial Skin, by Country USD Million (2019-2024)
  • Table 235. MEA Artificial Skin, by Type USD Million (2019-2024)
  • Table 236. MEA Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 237. MEA Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 238. MEA Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 239. Middle East Artificial Skin, by Type USD Million (2019-2024)
  • Table 240. Middle East Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 241. Middle East Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 242. Middle East Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 243. Africa Artificial Skin, by Type USD Million (2019-2024)
  • Table 244. Africa Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 245. Africa Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 246. Africa Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 247. North America Artificial Skin, by Country USD Million (2019-2024)
  • Table 248. North America Artificial Skin, by Type USD Million (2019-2024)
  • Table 249. North America Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 250. North America Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 251. North America Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 252. United States Artificial Skin, by Type USD Million (2019-2024)
  • Table 253. United States Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 254. United States Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 255. United States Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 256. Canada Artificial Skin, by Type USD Million (2019-2024)
  • Table 257. Canada Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 258. Canada Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 259. Canada Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 260. Mexico Artificial Skin, by Type USD Million (2019-2024)
  • Table 261. Mexico Artificial Skin, by Need of Patient USD Million (2019-2024)
  • Table 262. Mexico Artificial Skin, by Distribution Channel USD Million (2019-2024)
  • Table 263. Mexico Artificial Skin, by Material Type USD Million (2019-2024)
  • Table 264. Research Programs/Design for This Report
  • Table 265. Key Data Information from Secondary Sources
  • Table 266. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Skin: by Type USD Million (2013-2018)
  • Figure 5. Global Artificial Skin: by Need of Patient USD Million (2013-2018)
  • Figure 6. Global Artificial Skin: by Distribution Channel USD Million (2013-2018)
  • Figure 7. Global Artificial Skin: by Material Type USD Million (2013-2018)
  • Figure 8. South America Artificial Skin Share (%), by Country
  • Figure 9. Asia Pacific Artificial Skin Share (%), by Country
  • Figure 10. Europe Artificial Skin Share (%), by Country
  • Figure 11. MEA Artificial Skin Share (%), by Country
  • Figure 12. North America Artificial Skin Share (%), by Country
  • Figure 13. Global Artificial Skin share by Players 2018 (%)
  • Figure 14. Global Artificial Skin share by Players (Top 3) 2018(%)
  • Figure 15. Global Artificial Skin share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Integra Life Sciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Integra Life Sciences Corporation (United States) Revenue: by Geography 2018
  • Figure 19. Johnson & Johnson Services Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Johnson & Johnson Services Inc. (United States) Revenue: by Geography 2018
  • Figure 21. Mylan N.V. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Mylan N.V. (United Kingdom) Revenue: by Geography 2018
  • Figure 23. Mallinckrodt plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Mallinckrodt plc (United Kingdom) Revenue: by Geography 2018
  • Figure 25. Smith & Nephew plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Smith & Nephew plc (United Kingdom) Revenue: by Geography 2018
  • Figure 27. Shiseido Company, Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Shiseido Company, Limited (Japan) Revenue: by Geography 2018
  • Figure 29. Greiner Group AG (Austria) Revenue, Net Income and Gross profit
  • Figure 30. Greiner Group AG (Austria) Revenue: by Geography 2018
  • Figure 31. Stratatech Corporation (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Stratatech Corporation (United Kingdom) Revenue: by Geography 2018
  • Figure 33. Doctors Health Press (United States) Revenue, Net Income and Gross profit
  • Figure 34. Doctors Health Press (United States) Revenue: by Geography 2018
  • Figure 35. Global Artificial Skin: by Type USD Million (2019-2024)
  • Figure 36. Global Artificial Skin: by Need of Patient USD Million (2019-2024)
  • Figure 37. Global Artificial Skin: by Distribution Channel USD Million (2019-2024)
  • Figure 38. Global Artificial Skin: by Material Type USD Million (2019-2024)
  • Figure 39. South America Artificial Skin Share (%), by Country
  • Figure 40. Asia Pacific Artificial Skin Share (%), by Country
  • Figure 41. Europe Artificial Skin Share (%), by Country
  • Figure 42. MEA Artificial Skin Share (%), by Country
  • Figure 43. North America Artificial Skin Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Integra Life Sciences Corporation (United States)
  • Johnson & Johnson Services Inc. (United States)
  • Mylan N.V. (United Kingdom)
  • Mallinckrodt plc (United Kingdom)
  • Smith & Nephew plc (United Kingdom)
  • Shiseido Company, Limited (Japan)
  • Greiner Group AG (Austria)
  • Stratatech Corporation (United Kingdom)
  • Doctors Health Press (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation